v3.20.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Revenue    
Product revenue, net $ 11,946 $ 6,125
Revenue - related party 972 352
Net revenue 12,918 6,477
Operating expenses    
Cost of goods sold - product revenue 3,810 1,884
Research and development 14,867 23,273
Research and development - licenses acquired 250 450
General and administrative 15,519 13,478
Total operating expenses 34,446 39,085
Loss from operations (21,528) (32,608)
Other income (expense)    
Interest income 627 438
Interest expense and financing fee (3,125) (2,469)
Change in fair value of derivative liability (42) 0
Gain on deconsolidation of Caelum 0 18,384
Total other income (expense) (2,540) 16,353
Net loss (24,068) (16,255)
Less: net loss attributable to non-controlling interests 11,698 17,647
Net income (loss) attributable to common stockholders $ (12,370) $ 1,392
Net loss per common share - basic $ (0.38) $ (0.34)
Net loss per common share - diluted (0.38) (0.25)
Net income (loss) per common share attributable to common stockholders - basic (0.19) 0.03
Net income (loss) per common share attributable to common stockholders - diluted $ (0.19) $ 0.02
Weighted average common shares outstanding - basic 63,496,256 48,506,994
Weighted average common shares outstanding - diluted 63,496,256 63,811,136

Source